QIAGEN Price to Sales Ratio 2010-2022 | QGEN

Historical PS ratio values for QIAGEN (QGEN) over the last 10 years. The current P/S ratio for QIAGEN as of June 28, 2022 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
QIAGEN P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2022-06-28 46.83 4.70
2022-03-31 49.00 $9.97 4.91
2021-12-31 55.58 $9.72 5.72
2021-09-30 51.68 $9.65 5.36
2021-06-30 48.38 $9.39 5.15
2021-03-31 48.69 $8.84 5.51
2020-12-31 52.85 $7.99 6.62
2020-09-30 52.26 $7.37 7.09
2020-06-30 42.81 $7.01 6.11
2020-03-31 41.60 $6.75 6.16
2019-12-31 33.80 $6.64 5.09
2019-09-30 32.97 $6.55 5.03
2019-06-30 40.55 $6.47 6.27
2019-03-31 40.68 $6.44 6.32
2018-12-31 34.45 $6.43 5.36
2018-09-30 37.88 $6.40 5.92
2018-06-30 36.16 $6.36 5.69
2018-03-31 32.31 $6.24 5.17
2017-12-31 30.93 $6.08 5.09
2017-09-30 31.50 $5.91 5.33
2017-06-30 33.53 $5.76 5.82
2017-03-31 28.97 $5.66 5.12
2016-12-31 29.10 $5.60 5.19
2016-09-30 28.50 $5.53 5.15
2016-06-30 22.65 $5.49 4.12
2016-03-31 23.20 $5.49 4.23
2015-12-31 28.71 $5.54 5.18
2015-09-30 26.81 $5.57 4.82
2015-06-30 25.74 $5.64 4.57
2015-03-31 26.17 $5.66 4.62
2014-12-31 24.36 $5.71 4.26
2014-09-30 23.65 $5.78 4.09
2014-06-30 25.39 $5.71 4.45
2014-03-31 21.90 $5.68 3.85
2013-12-31 24.73 $5.63 4.39
2013-09-30 22.22 $5.58 3.98
2013-06-30 20.68 $5.50 3.76
2013-03-31 21.89 $5.43 4.03
2012-12-31 18.85 $5.42 3.48
2012-09-30 19.22 $5.37 3.58
2012-06-30 17.34 $5.33 3.25
2012-03-31 16.17 $5.22 3.10
2011-12-31 14.34 $5.07 2.83
2011-09-30 14.36 $4.86 2.96
2011-06-30 19.75 $4.79 4.12
2011-03-31 20.82 $4.70 4.43
2010-12-31 20.30 $4.73 4.30
2010-09-30 18.42 $4.73 3.89
2010-06-30 19.96 $4.83 4.13
2010-03-31 23.87 $4.93 4.84
2009-12-31 23.19 $4.89 4.74
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.670B $2.252B
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $170.283B 10.36
Bio-Rad Laboratories (BIO.B) United States $14.121B 30.63
Biohaven Pharmaceutical Holding (BHVN) United States $10.157B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.957B 0.00
Arcus Biosciences (RCUS) United States $1.815B 46.02
Emergent Biosolutions (EBS) United States $1.640B 7.02
Myovant Sciences (MYOV) United Kingdom $1.243B 0.00
Zymeworks (ZYME) Canada $0.354B 0.00
Gelesis Holdings (GLS) United States $0.114B 0.00
Enzo Biochem (ENZ) United States $0.098B 0.00
Ambrx Biopharma (AMAM) United States $0.098B 0.00
SQZ Biotechnologies (SQZ) United States $0.095B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00